Search

Your search keyword '"Glaucoma -- Care and treatment"' showing total 109 results

Search Constraints

Start Over You searched for: Descriptor "Glaucoma -- Care and treatment" Remove constraint Descriptor: "Glaucoma -- Care and treatment" Publisher ubm llc Remove constraint Publisher: ubm llc
109 results on '"Glaucoma -- Care and treatment"'

Search Results

1. Your glaucoma patients also have ocular surface disease: Employ treatment strategies that control both conditions with less reliance on drops

2. Navigating New Approaches for Glaucoma Management: THE ROLE OF NITRIC OXIDE

3. Evolving Role of Subconjunctival MIGS: A CASE-BASED DISCUSSION

5. Novel DSLT taking aim at glaucoma care: Automated, transscleral, 1-second procedure holds promise for increasing accessibility to IOP-lowering

6. Travoprost eluting drug-delivery device shows promise

7. Understanding drainage in surgery: procedures and practices for postoperative care

8. Novel modalities expand therapeutic arsenal in glaucoma management: IOP-lowering therapies will remain relevant in future of disease treatment

14. Setting expectations for glaucoma patients having cataract surgery: Pearls can ensure physicians get best outcomes, help patients set realistic goals

15. Hypotony more than just a number; consider symptoms during therapy: While numerous techniques are available to surgeons, awareness is important

16. Phaco effective approach for angle-closure glaucoma: Clinical evidence, hands-on experience yields pearls for physicians

17. Techniques, tips for successful glaucoma tube shunt surgery: Some finesse may go a long way for physicians to ensure best possible result for patients

18. Pearls to manage cataract surgery on hypotonous eyes: Better visual outcomes goal for patients who also have had glaucoma procedure

19. Intraoperative techniques in glaucoma focus on avoiding issues: Postoperative complications can have multiple causes and preventative measures

21. Quality-of-life metrics improve glaucoma staging: Adding this data to clinical decision making may help patient treatment goals

22. Gel stent optimizes aqueous drainage: device said to be as effective as trabeculectomy, can be used early with less surgical side effects

24. Glaucoma devices: Offering innovation now and in the future: Panel of thought leaders discusses IOP monitoring, drug delivery, data collection

26. Pearls for managing COVID-19 pandemic north of the border: Canadian ophthalmologists receive updates on best practices amid coronavirus outbreak

28. OCT ARTIFACTS AND PITFALLS: IN THE EYE OF THE BEHOLDER: Scans correlate structure with function of the optic nerve in glaucoma patients

30. LIGHT Trial focuses on lowering IOP, keeping it there: Repeat-SLT proves to be successful as long-term treatment option

31. Managing aqueous misdirection syndrome via myriad approaches

32. Looking beyond IOP when managing glaucoma patients: Nutrition is a potentially preventative therapy that should be supplementary to treatment

33. How MIGS benefits those with the greatest of needs: Charitable missions provide long-lasting care to patients in underserved areas of the world

36. Dangers of starting, stopping glaucoma treatment: Keeping patients committed to prescribed treatment is key to success

37. Breaking down the dorzolamide shortage; impact on patients: Shortages reveal how generic molecules are supplied in ophthalmology industry

39. Managing cataracts in glaucoma patients: A rock-hard case: Challenging procedures often require a deft approach by surgeons

40. Cataract surgery in uveitic glaucoma eye can have good result: Physicians also can focus on treating inflammation and IOP in patients

41. Tools, techniques for cataract surgery in PFX glaucoma patients: Applying a cautious approach can increase the chance for successful outcomes

42. Consider the whole patient when treating glaucoma: Look beyond ophthalmic indicators to consider the impact of biomarkers

43. Novel IOP-lowering medication finds utility in glaucoma patient care: Latanoprostene bunod especially useful to patients who do not respond to first-line therapy

44. Know when to delegate testing responsibilities: ODs need to determine which glaucoma tasks to perform or assign to staff

45. Micropulse TSCPC changing mindset for early-stage glaucoma disease: 'Gentler' laser application/treatment modality remains efficacious at lowering IOP in study

46. New world order of glaucoma presenting strong challenges

47. Novel drug delivery platforms: filling a 'GAP' in glaucoma

48. Three reasons for adopting DMEK in routine EK cases: improved visual results, lower rejection rate, less steroid-induced glaucoma among benefits

Catalog

Books, media, physical & digital resources